For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Editas Medicine Inc’s stock clocked out at $1.25, down -3.85% from its previous closing price of $1.30. In other words, the price has decreased by -$3.85 from its previous closing price. On the day, 1.14 million shares were traded. EDIT stock price reached its highest trading level at $1.3106 during the session, while it also had its lowest trading level at $1.24.
Ratios:
To gain a deeper understanding of EDIT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.15.
Stifel Downgraded its Buy to Hold on December 13, 2024, whereas the target price for the stock was revised from $11 to $3.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Lucera Erick sold 4,109 shares for $1.71 per share. The transaction valued at 7,030 led to the insider holds 112,720 shares of the business.
O’Neill Gilmore Neil sold 16,632 shares of EDIT for $28,452 on Mar 04 ’25. The CEO now owns 295,474 shares after completing the transaction at $1.71 per share. On Mar 04 ’25, another insider, Burkly Linda, who serves as the EVP, CHIEF SCIENTIFIC OFFICER of the company, sold 2,891 shares for $1.71 each. As a result, the insider received 4,946 and left with 70,245 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 103720384 and an Enterprise Value of -131160648. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.21 while its Price-to-Book (P/B) ratio in mrq is 0.77. Its current Enterprise Value per Revenue stands at -4.059 whereas that against EBITDA is 0.563.
Stock Price History:
The Beta on a monthly basis for EDIT is 2.12, which has changed by -0.8282967 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $7.52, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -17.16%, while the 200-Day Moving Average is calculated to be -58.01%.
Shares Statistics:
It appears that EDIT traded 3.92M shares on average per day over the past three months and 1728460 shares per day over the past ten days. A total of 82.73M shares are outstanding, with a floating share count of 82.23M. Insiders hold about 0.91% of the company’s shares, while institutions hold 62.52% stake in the company. Shares short for EDIT as of 1741910400 were 13149670 with a Short Ratio of 3.36, compared to 1739491200 on 17438018. Therefore, it implies a Short% of Shares Outstanding of 13149670 and a Short% of Float of 20.040001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
